|
G |
ABCC3 |
ATP binding cassette subfamily C member 3 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of ABCC3 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
|
|
G |
ABHD12B |
abhydrolase domain containing 12B |
increases expression |
EXP |
cinnamaldehyde results in increased expression of ABHD12B mRNA |
CTD |
PMID:19524605 |
|
NCBI chr14:50,872,053...50,904,970
Ensembl chr14:50,872,053...50,904,970
|
|
G |
ACTA2 |
actin alpha 2, smooth muscle |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [Glucose results in increased expression of ACTA2 protein] |
CTD |
PMID:20060012 |
|
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,934,822...88,991,339
|
|
G |
ACTB |
actin beta |
increases metabolic processing |
EXP |
cinnamaldehyde results in increased metabolism of ACTB protein |
CTD |
PMID:29267982 |
|
NCBI chr 7:5,527,148...5,530,601
Ensembl chr 7:5,526,409...5,563,902
|
|
G |
ADAM23 |
ADAM metallopeptidase domain 23 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of ADAM23 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 2:206,443,532...206,621,127
Ensembl chr 2:206,443,532...206,621,127
|
|
G |
ADK |
adenosine kinase |
increases expression |
EXP |
cinnamaldehyde results in increased expression of ADK mRNA |
CTD |
PMID:19524605 |
|
NCBI chr10:74,151,221...74,709,290
Ensembl chr10:74,151,202...74,709,963
|
|
G |
ADM |
adrenomedullin |
increases expression |
EXP |
cinnamaldehyde results in increased expression of ADM mRNA |
CTD |
PMID:19524605 |
|
NCBI chr11:10,305,073...10,307,397
Ensembl chr11:10,305,073...10,307,397
|
|
G |
AGER |
advanced glycosylation end-product specific receptor |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of AGER protein] |
CTD |
PMID:33522063 |
|
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
|
|
G |
AKR1B10 |
aldo-keto reductase family 1 member B10 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of AKR1B10 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
|
|
G |
AKR1C1 |
aldo-keto reductase family 1 member C1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of AKR1C1 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr10:4,963,415...4,983,283
Ensembl chr10:4,963,253...4,983,283
|
|
G |
AKR1C2 |
aldo-keto reductase family 1 member C2 |
increases activity increases expression multiple interactions |
EXP |
cinnamaldehyde results in increased activity of AKR1C2 promoter cinnamaldehyde results in increased expression of AKR1C2 mRNA NFE2L2 mRNA promotes the reaction [cinnamaldehyde results in increased expression of AKR1C2 mRNA] |
CTD |
PMID:21195160 PMID:25724174 PMID:26244607 |
|
NCBI chr10:4,987,775...5,018,000
Ensembl chr10:4,987,775...5,018,031
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
increases phosphorylation multiple interactions |
EXP ISO |
cinnamaldehyde results in increased phosphorylation of AKT1 protein cinnamaldehyde inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:20467561 PMID:21469739 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
|
|
G |
ALB |
albumin |
increases metabolic processing |
EXP |
cinnamaldehyde results in increased metabolism of ALB protein |
CTD |
PMID:29267982 |
|
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
ALS2 |
alsin Rho guanine nucleotide exchange factor ALS2 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of ALS2 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 2:201,700,267...201,780,933
Ensembl chr 2:201,700,267...201,782,112
|
|
G |
AMPD3 |
adenosine monophosphate deaminase 3 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of AMPD3 mRNA |
CTD |
PMID:24211530 |
|
NCBI chr11:10,450,388...10,507,579
Ensembl chr11:10,308,313...10,507,579
|
|
G |
ARHGAP23 |
Rho GTPase activating protein 23 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of ARHGAP23 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr17:38,419,275...38,512,385
Ensembl chr17:38,419,280...38,512,385
|
|
G |
ATF3 |
activating transcription factor 3 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of ATF3 mRNA |
CTD |
PMID:23999411 PMID:27965148 |
|
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
|
|
G |
ATP11A |
ATPase phospholipid transporting 11A |
increases expression |
EXP |
cinnamaldehyde results in increased expression of ATP11A mRNA |
CTD |
PMID:19524605 |
|
NCBI chr13:112,690,038...112,887,168
Ensembl chr13:112,690,038...112,887,168
|
|
G |
B2M |
beta-2-microglobulin |
decreases expression |
ISO |
cinnamaldehyde results in decreased expression of B2M mRNA |
CTD |
PMID:28219650 |
|
NCBI chr15:44,711,517...44,718,145
Ensembl chr15:44,711,358...44,718,851
|
|
G |
BACH1 |
BTB domain and CNC homolog 1 |
multiple interactions |
EXP |
BACH1 mRNA promotes the reaction [cinnamaldehyde results in increased expression of HMOX1 mRNA] |
CTD |
PMID:26244607 |
|
NCBI chr21:29,298,922...29,361,894
Ensembl chr21:29,194,071...29,630,751
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
EXP ISO |
cinnamaldehyde results in increased expression of BAX protein cinnamaldehyde inhibits the reaction [Testosterone results in decreased expression of BAX mRNA] Vitamin E inhibits the reaction [cinnamaldehyde results in increased expression of BAX protein] |
CTD |
PMID:15566391 PMID:15964311 PMID:32628957 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCAP29 |
B cell receptor associated protein 29 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of BCAP29 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 7:107,580,007...107,623,317
Ensembl chr 7:107,580,246...107,629,170
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
decreases expression multiple interactions |
EXP ISO |
cinnamaldehyde analog results in decreased expression of BCL2 protein; cinnamaldehyde results in decreased expression of BCL2 protein cinnamaldehyde inhibits the reaction [Testosterone results in increased expression of BCL2 mRNA] Vitamin E inhibits the reaction [cinnamaldehyde results in decreased expression of BCL2 protein] |
CTD |
PMID:15566391 PMID:15964311 PMID:17510524 PMID:32628957 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BID |
BH3 interacting domain death agonist |
increases cleavage |
EXP |
cinnamaldehyde results in increased cleavage of BID protein |
CTD |
PMID:15964311 |
|
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
|
|
G |
BIRC2 |
baculoviral IAP repeat containing 2 |
multiple interactions decreases expression |
EXP |
Vitamin E inhibits the reaction [cinnamaldehyde results in decreased expression of BIRC2 protein] |
CTD |
PMID:15566391 |
|
NCBI chr11:102,347,214...102,378,670
Ensembl chr11:102,347,211...102,378,670
|
|
G |
BIRC3 |
baculoviral IAP repeat containing 3 |
multiple interactions decreases expression |
EXP |
Vitamin E inhibits the reaction [cinnamaldehyde results in decreased expression of BIRC3 protein] |
CTD |
PMID:15566391 |
|
NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,484...102,339,403
|
|
G |
CASP1 |
caspase 1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of CASP1 mRNA |
CTD |
PMID:19000754 |
|
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
|
|
G |
CASP3 |
caspase 3 |
increases cleavage increases expression multiple interactions increases activity |
EXP |
cinnamaldehyde results in increased cleavage of CASP3 protein cinnamaldehyde analog results in increased expression of CASP3 protein Vitamin E inhibits the reaction [cinnamaldehyde results in increased activity of CASP3 protein] cinnamaldehyde analog results in increased activity of CASP3 protein; cinnamaldehyde results in increased activity of CASP3 protein |
CTD |
PMID:15566391 PMID:16343908 PMID:17510524 PMID:19000754 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP8 |
caspase 8 |
increases activity |
EXP |
cinnamaldehyde results in increased activity of CASP8 protein |
CTD |
PMID:15964311 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
decreases expression |
ISO |
cinnamaldehyde results in decreased expression of CASP9 mRNA |
CTD |
PMID:28219650 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
increases expression multiple interactions decreases activity |
ISO |
cinnamaldehyde results in increased expression of CAT mRNA NFE2L2 protein promotes the reaction [cinnamaldehyde results in increased expression of CAT mRNA] cinnamaldehyde inhibits the reaction [Cisplatin results in decreased activity of CAT protein] cinnamaldehyde results in decreased activity of CAT protein |
CTD |
PMID:17076691 PMID:23959918 PMID:28219650 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCDC34 |
coiled-coil domain containing 34 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of CCDC34 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr11:27,338,512...27,363,215
Ensembl chr11:27,330,827...27,363,234
|
|
G |
CCL20 |
C-C motif chemokine ligand 20 |
affects expression increases expression |
ISO EXP |
cinnamaldehyde affects the expression of CCL20 mRNA cinnamaldehyde results in increased expression of CCL20 mRNA |
CTD |
PMID:28219650 PMID:30806763 |
|
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
|
|
G |
CCL22 |
C-C motif chemokine ligand 22 |
decreases expression |
ISO |
cinnamaldehyde results in decreased expression of CCL22 mRNA |
CTD |
PMID:28219650 |
|
NCBI chr16:57,357,909...57,366,189
Ensembl chr16:57,358,783...57,366,189
|
|
G |
CCL3 |
C-C motif chemokine ligand 3 |
multiple interactions affects expression increases secretion |
ISO EXP |
NFE2L2 protein inhibits the reaction [cinnamaldehyde results in increased expression of CCL3 mRNA] cinnamaldehyde affects the expression of CCL3 mRNA cinnamaldehyde results in increased secretion of CCL3 protein |
CTD |
PMID:23624239 PMID:28219650 |
|
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
|
|
G |
CCL4 |
C-C motif chemokine ligand 4 |
affects expression increases secretion |
ISO EXP |
cinnamaldehyde affects the expression of CCL4 mRNA cinnamaldehyde results in increased secretion of CCL4 protein |
CTD |
PMID:28219650 PMID:30806763 |
|
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
decreases expression increases secretion |
ISO EXP |
cinnamaldehyde results in decreased expression of CCL5 mRNA cinnamaldehyde results in increased secretion of CCL5 protein |
CTD |
PMID:20488241 PMID:28219650 |
|
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
|
|
G |
CCN2 |
cellular communication network factor 2 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of CCN2 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
|
|
G |
CCND1 |
cyclin D1 |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [Testosterone results in increased expression of CCND1 protein] |
CTD |
PMID:32628957 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CD274 |
CD274 molecule |
increases expression |
EXP |
cinnamaldehyde results in increased expression of CD274 protein |
CTD |
PMID:20488241 PMID:23624239 |
|
NCBI chr 9:5,450,542...5,470,554
Ensembl chr 9:5,450,503...5,470,566
|
|
G |
CD80 |
CD80 molecule |
increases expression |
ISO |
cinnamaldehyde results in increased expression of CD80 mRNA |
CTD |
PMID:28219650 |
|
NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
|
|
G |
CD83 |
CD83 molecule |
decreases expression increases expression |
ISO EXP |
cinnamaldehyde results in decreased expression of CD83 mRNA cinnamaldehyde results in increased expression of CD83 mRNA |
CTD |
PMID:27196738 PMID:28219650 |
|
NCBI chr 6:14,117,256...14,136,918
Ensembl chr 6:14,117,256...14,136,918
|
|
G |
CD86 |
CD86 molecule |
decreases expression increases expression |
ISO EXP |
cinnamaldehyde results in decreased expression of CD86 mRNA cinnamaldehyde results in increased expression of CD86 protein cinnamaldehyde results in increased expression of CD86 mRNA; cinnamaldehyde results in increased expression of CD86 protein |
CTD |
PMID:11244134 PMID:19524605 PMID:19665512 PMID:20488241 PMID:23624239 PMID:28219650 PMID:30806763 More...
|
|
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
|
|
G |
CDC25B |
cell division cycle 25B |
decreases activity |
EXP |
cinnamaldehyde analog results in decreased activity of CDC25B protein |
CTD |
PMID:16343908 |
|
NCBI chr20:3,786,951...3,806,115
Ensembl chr20:3,786,772...3,806,121
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
increases expression |
EXP |
cinnamaldehyde results in increased expression of CDKN1A mRNA; cinnamaldehyde results in increased expression of CDKN1A protein |
CTD |
PMID:19000754 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
|
|
G |
CEBPA |
CCAAT enhancer binding protein alpha |
decreases expression |
ISO |
cinnamaldehyde results in decreased expression of CEBPA mRNA |
CTD |
PMID:21401097 |
|
NCBI chr19:33,299,934...33,302,534
Ensembl chr19:33,299,934...33,302,534
|
|
G |
CES1 |
carboxylesterase 1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of CES1 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr16:55,802,851...55,833,096
Ensembl chr16:55,802,851...55,833,337
|
|
G |
CHUK |
component of inhibitor of nuclear factor kappa B kinase complex |
decreases phosphorylation |
ISO |
cinnamaldehyde results in decreased phosphorylation of CHUK protein |
CTD |
PMID:17486422 |
|
NCBI chr10:100,186,319...100,229,596
Ensembl chr10:100,188,300...100,229,596
|
|
G |
CLEC4A |
C-type lectin domain family 4 member A |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of CLEC4A protein |
CTD |
PMID:23624239 |
|
NCBI chr12:8,102,907...8,138,607
Ensembl chr12:8,123,617...8,138,607
|
|
G |
CLK2 |
CDC like kinase 2 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of CLK2 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr 1:155,262,868...155,273,504
Ensembl chr 1:155,262,868...155,278,491
|
|
G |
CNOT2 |
CCR4-NOT transcription complex subunit 2 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of CNOT2 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr12:70,243,018...70,354,993
Ensembl chr12:70,243,002...70,354,993
|
|
G |
COL7A1 |
collagen type VII alpha 1 chain |
increases expression |
EXP |
cinnamaldehyde results in increased expression of COL7A1 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 3:48,564,073...48,595,329
Ensembl chr 3:48,564,073...48,595,329
|
|
G |
CREB1 |
cAMP responsive element binding protein 1 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of CREB1 mRNA |
CTD |
PMID:20385217 |
|
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
|
|
G |
CREM |
cAMP responsive element modulator |
increases expression |
EXP |
cinnamaldehyde results in increased expression of CREM mRNA |
CTD |
PMID:19524605 |
|
NCBI chr10:35,126,846...35,212,958
Ensembl chr10:35,126,791...35,212,958
|
|
G |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of CRIM1 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 2:36,355,778...36,551,135
Ensembl chr 2:36,355,778...36,551,135
|
|
G |
CRKL |
CRK like proto-oncogene, adaptor protein |
decreases phosphorylation |
EXP |
cinnamaldehyde results in decreased phosphorylation of CRKL protein |
CTD |
PMID:21729535 |
|
NCBI chr22:20,917,407...20,953,747
Ensembl chr22:20,917,407...20,953,747
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
increases expression multiple interactions affects expression |
EXP ISO |
cinnamaldehyde results in increased expression of CXCL1 mRNA NFE2L2 protein inhibits the reaction [cinnamaldehyde results in increased expression of CXCL1 mRNA] cinnamaldehyde affects the expression of CXCL1 mRNA |
CTD |
PMID:28219650 PMID:30806763 |
|
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
increases expression multiple interactions |
ISO |
cinnamaldehyde results in increased expression of CXCL10 mRNA NFE2L2 protein inhibits the reaction [cinnamaldehyde results in increased expression of CXCL10 mRNA] |
CTD |
PMID:28219650 |
|
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
|
|
G |
CXCL14 |
C-X-C motif chemokine ligand 14 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of CXCL14 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 5:135,570,679...135,578,991
Ensembl chr 5:135,570,679...135,579,279
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
increases secretion multiple interactions increases expression |
EXP |
cinnamaldehyde results in increased secretion of CXCL8 protein Betamethasone inhibits the reaction [cinnamaldehyde results in increased expression of CXCL8 mRNA]; cinnamaldehyde results in increased expression of and results in increased secretion of CXCL8 protein; SB 203580 affects the reaction [cinnamaldehyde results in increased secretion of CXCL8 protein]; Tacrolimus inhibits the reaction [cinnamaldehyde results in increased expression of CXCL8 mRNA] cinnamaldehyde results in increased expression of CXCL8 mRNA; cinnamaldehyde results in increased expression of CXCL8 protein |
CTD |
PMID:18494145 PMID:19524605 PMID:19878716 PMID:20090409 PMID:20713136 PMID:21920952 PMID:23624239 PMID:25290854 PMID:27965148 PMID:30806763 More...
|
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CXCR1 |
C-X-C motif chemokine receptor 1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of CXCR1 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 2:218,162,841...218,166,962
Ensembl chr 2:218,162,841...218,166,962
|
|
G |
CXCR4 |
C-X-C motif chemokine receptor 4 |
decreases expression |
ISO |
cinnamaldehyde results in decreased expression of CXCR4 mRNA |
CTD |
PMID:28219650 |
|
NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
|
|
G |
CYCS |
cytochrome c, somatic |
affects localization multiple interactions |
EXP |
cinnamaldehyde affects the localization of CYCS protein Vitamin E inhibits the reaction [cinnamaldehyde affects the localization of CYCS protein] |
CTD |
PMID:15566391 |
|
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of CYP1A1 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP2A6 |
cytochrome P450 family 2 subfamily A member 6 |
decreases activity multiple interactions |
EXP |
cinnamaldehyde results in decreased activity of CYP2A6 protein [[cinnamaldehyde results in decreased activity of CYP2A6 protein] which results in decreased hydroxylation of 3-cyanocoumarin] which results in decreased chemical synthesis of 3-cyano-7-hydroxycoumarin; [cinnamaldehyde results in decreased activity of CYP2A6 protein] which results in decreased hydroxylation of 3-cyanocoumarin |
CTD |
PMID:32496054 |
|
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
|
|
G |
CYP7A1 |
cytochrome P450 family 7 subfamily A member 1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of CYP7A1 mRNA |
CTD |
PMID:19000754 |
|
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of DDIT3 mRNA |
CTD |
PMID:19000754 |
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
DDIT4 |
DNA damage inducible transcript 4 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of DDIT4 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
|
|
G |
DIABLO |
diablo IAP-binding mitochondrial protein |
affects localization multiple interactions |
EXP |
cinnamaldehyde affects the localization of DIABLO protein Vitamin E inhibits the reaction [cinnamaldehyde affects the localization of DIABLO protein] |
CTD |
PMID:15566391 |
|
NCBI chr12:122,207,662...122,227,456
Ensembl chr12:122,207,668...122,226,062
|
|
G |
DMTN |
dematin actin binding protein |
increases expression |
EXP |
cinnamaldehyde results in increased expression of DMTN mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 8:22,048,931...22,082,525
Ensembl chr 8:22,048,995...22,082,527
|
|
G |
DNAJB4 |
DnaJ heat shock protein family (Hsp40) member B4 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of DNAJB4 mRNA |
CTD |
PMID:23999411 PMID:27965148 |
|
NCBI chr 1:77,979,175...78,017,964
Ensembl chr 1:77,979,175...78,017,964
|
|
G |
DNMT3B |
DNA methyltransferase 3 beta |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of DNMT3B mRNA |
CTD |
PMID:17178418 |
|
NCBI chr20:32,762,385...32,809,356
Ensembl chr20:32,762,385...32,809,359
|
|
G |
DUSP1 |
dual specificity phosphatase 1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of DUSP1 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
|
|
G |
DUSP6 |
dual specificity phosphatase 6 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of DUSP6 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501
|
|
G |
DYNLRB1 |
dynein light chain roadblock-type 1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of DYNLRB1 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr20:34,515,602...34,540,958
Ensembl chr20:34,516,395...34,540,958
|
|
G |
EAF2 |
ELL associated factor 2 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of EAF2 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 3:121,835,209...121,886,526
Ensembl chr 3:121,835,183...121,886,526
|
|
G |
EGR1 |
early growth response 1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of EGR1 mRNA |
CTD |
PMID:19000754 |
|
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
|
|
G |
EIF3A |
eukaryotic translation initiation factor 3 subunit A |
increases metabolic processing |
EXP |
cinnamaldehyde results in increased metabolism of EIF3A protein |
CTD |
PMID:29267982 |
|
NCBI chr10:119,033,670...119,080,817
Ensembl chr10:119,033,670...119,080,817
|
|
G |
EPAS1 |
endothelial PAS domain protein 1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of EPAS1 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 2:46,297,407...46,386,697
Ensembl chr 2:46,293,667...46,386,697
|
|
G |
F2RL1 |
F2R like trypsin receptor 1 |
multiple interactions |
EXP |
edelfosine inhibits the reaction [F2RL1 protein promotes the reaction [cinnamaldehyde results in increased activity of TRPA1 protein]]; F2RL1 protein promotes the reaction [cinnamaldehyde results in increased activity of TRPA1 protein] |
CTD |
PMID:17571167 |
|
NCBI chr 5:76,819,030...76,835,315
Ensembl chr 5:76,818,933...76,835,315
|
|
G |
FABP4 |
fatty acid binding protein 4 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of FABP4 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 8:81,478,419...81,483,233
Ensembl chr 8:81,478,419...81,483,236
|
|
G |
FAS |
Fas cell surface death receptor |
multiple interactions decreases expression |
ISO |
dorsomorphin inhibits the reaction [cinnamaldehyde results in decreased expression of FAS mRNA] |
CTD |
PMID:21401097 |
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FCGR2B |
Fc gamma receptor IIb |
increases expression |
EXP |
cinnamaldehyde results in increased expression of FCGR2B mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 1:161,647,243...161,678,654
Ensembl chr 1:161,663,143...161,678,654
|
|
G |
FCGR2C |
Fc gamma receptor IIc (gene/pseudogene) |
increases expression |
EXP |
cinnamaldehyde results in increased expression of FCGR2C mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 1:161,581,339...161,601,220
Ensembl chr 1:161,581,339...161,605,662
|
|
G |
FGFR2 |
fibroblast growth factor receptor 2 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of FGFR2 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr10:121,478,330...121,598,458
Ensembl chr10:121,478,332...121,598,458
|
|
G |
FMO5 |
flavin containing dimethylaniline monoxygenase 5 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of FMO5 mRNA |
CTD |
PMID:19000754 |
|
NCBI chr 1:147,184,305...147,227,284
Ensembl chr 1:147,175,351...147,243,050
|
|
G |
FN1 |
fibronectin 1 |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [Glucose results in increased expression of FN1 protein] |
CTD |
PMID:20060012 |
|
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
EXP |
cinnamaldehyde analog results in decreased expression of FOS protein |
CTD |
PMID:17510524 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
|
|
G |
FTH1 |
ferritin heavy chain 1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of FTH1 mRNA |
CTD |
PMID:19524605 PMID:24211530 |
|
NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634
|
|
G |
FTL |
ferritin light chain |
increases expression |
EXP |
cinnamaldehyde results in increased expression of FTL mRNA |
CTD |
PMID:24211530 |
|
NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,966,879
|
|
G |
FZD2 |
frizzled class receptor 2 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of FZD2 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr17:44,557,484...44,561,262
Ensembl chr17:44,557,484...44,561,262
|
|
G |
G6PD |
glucose-6-phosphate dehydrogenase |
increases expression |
EXP |
cinnamaldehyde results in increased expression of G6PD mRNA |
CTD |
PMID:19524605 |
|
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
|
|
G |
GCLC |
glutamate-cysteine ligase catalytic subunit |
increases expression multiple interactions |
EXP |
cinnamaldehyde results in increased expression of GCLC mRNA; cinnamaldehyde results in increased expression of GCLC protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [cinnamaldehyde results in increased expression of GCLC protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cinnamaldehyde results in increased expression of GCLC protein]; [cinnamaldehyde results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA; NFE2L2 mRNA affects the reaction [cinnamaldehyde results in increased expression of GCLC protein]; pyrazolanthrone inhibits the reaction [cinnamaldehyde results in increased expression of GCLC protein] |
CTD |
PMID:17178418 PMID:20351055 PMID:21469739 PMID:30806763 |
|
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
|
|
G |
GCLM |
glutamate-cysteine ligase modifier subunit |
multiple interactions increases expression |
EXP |
[cinnamaldehyde results in increased activity of NFE2L2 protein] which results in increased expression of GCLM mRNA cinnamaldehyde results in increased expression of GCLM mRNA |
CTD |
PMID:17178418 PMID:20351055 PMID:23999411 PMID:24211530 PMID:27965148 PMID:30806763 More...
|
|
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
|
|
G |
GLRX |
glutaredoxin |
increases expression increases activity multiple interactions |
EXP |
cinnamaldehyde results in increased expression of GLRX mRNA cinnamaldehyde results in increased activity of GLRX protein [Cadmium Chloride affects the activity of GLRX protein] inhibits the reaction [cinnamaldehyde results in increased glutathionylation of RELA protein]; [cinnamaldehyde results in increased activity of GLRX protein] inhibits the reaction [TNF protein affects the localization of RELA protein]; [cinnamaldehyde results in increased activity of GLRX protein] inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; [cinnamaldehyde results in increased activity of GLRX protein] which results in increased glutathionylation of RELA protein |
CTD |
PMID:20351055 |
|
NCBI chr 5:95,813,849...95,822,726
Ensembl chr 5:95,751,319...95,822,726
|
|
G |
GPR21 |
G protein-coupled receptor 21 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of GPR21 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 9:123,033,667...123,049,103
Ensembl chr 9:123,033,667...123,035,665
|
|
G |
GPX1 |
glutathione peroxidase 1 |
affects expression multiple interactions |
ISO |
cinnamaldehyde affects the expression of GPX1 mRNA NFE2L2 protein promotes the reaction [cinnamaldehyde results in increased expression of GPX1 mRNA] |
CTD |
PMID:28219650 |
|
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
|
|
G |
GPX2 |
glutathione peroxidase 2 |
multiple interactions affects expression increases expression |
ISO EXP |
NFE2L2 protein promotes the reaction [cinnamaldehyde results in increased expression of GPX2 mRNA] cinnamaldehyde affects the expression of GPX2 mRNA |
CTD |
PMID:19000754 PMID:28219650 |
|
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
|
|
G |
GPX5 |
glutathione peroxidase 5 |
affects expression multiple interactions |
ISO |
cinnamaldehyde affects the expression of GPX5 mRNA NFE2L2 protein promotes the reaction [cinnamaldehyde results in increased expression of GPX5 mRNA] |
CTD |
PMID:28219650 |
|
NCBI chr 6:28,525,881...28,534,955
Ensembl chr 6:28,525,881...28,534,955
|
|
G |
GPX6 |
glutathione peroxidase 6 |
multiple interactions affects expression |
ISO |
NFE2L2 protein promotes the reaction [cinnamaldehyde results in increased expression of GPX6 mRNA] cinnamaldehyde affects the expression of GPX6 mRNA |
CTD |
PMID:28219650 |
|
NCBI chr 6:28,503,296...28,515,793
Ensembl chr 6:28,503,296...28,528,215
|
|
G |
GPX7 |
glutathione peroxidase 7 |
decreases expression |
ISO |
cinnamaldehyde results in decreased expression of GPX7 mRNA |
CTD |
PMID:28219650 |
|
NCBI chr 1:52,602,371...52,609,051
Ensembl chr 1:52,602,371...52,609,051
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
decreases expression |
ISO |
cinnamaldehyde results in decreased expression of GSK3B mRNA |
CTD |
PMID:28219650 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
G |
GSR |
glutathione-disulfide reductase |
multiple interactions increases expression |
ISO EXP |
NFE2L2 protein promotes the reaction [cinnamaldehyde results in increased expression of GSR mRNA] |
CTD |
PMID:19000754 PMID:28219650 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
GSTM1 |
glutathione S-transferase mu 1 |
increases expression |
ISO |
cinnamaldehyde results in increased expression of GSTM1 mRNA |
CTD |
PMID:28219650 |
|
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
|
|
G |
GSTP1 |
glutathione S-transferase pi 1 |
multiple interactions |
EXP |
cinnamaldehyde binds to and results in decreased activity of GSTP1 protein |
CTD |
PMID:9463521 |
|
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
|
|
G |
GSTT1 |
glutathione S-transferase theta 1 |
affects expression |
ISO |
cinnamaldehyde affects the expression of GSTT1 mRNA |
CTD |
PMID:28219650 |
|
|
|
G |
H4C1 |
H4 clustered histone 1 |
increases metabolic processing |
EXP |
cinnamaldehyde results in increased metabolism of H4C1 protein |
CTD |
PMID:29267982 |
|
NCBI chr 6:26,021,649...26,022,050
Ensembl chr 6:26,021,649...26,022,050
|
|
G |
HBB |
hemoglobin subunit beta |
increases metabolic processing |
EXP |
cinnamaldehyde results in increased metabolism of HBB protein |
CTD |
PMID:29267982 |
|
NCBI chr11:5,225,464...5,227,071
Ensembl chr11:5,225,464...5,229,395
|
|
G |
HFE |
homeostatic iron regulator |
increases expression |
EXP |
cinnamaldehyde results in increased expression of HFE mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 6:26,087,429...26,098,343
Ensembl chr 6:26,087,226...26,098,343
|
|
G |
HMGB1 |
high mobility group box 1 |
decreases expression |
ISO |
cinnamaldehyde results in decreased expression of HMGB1 mRNA |
CTD |
PMID:28219650 |
|
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
|
|
G |
HMOX1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO EXP |
cinnamaldehyde results in increased expression of HMOX1 mRNA cinnamaldehyde inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of HMOX1 protein] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [cinnamaldehyde results in increased expression of HMOX1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cinnamaldehyde results in increased expression of HMOX1 protein]; BACH1 mRNA promotes the reaction [cinnamaldehyde results in increased expression of HMOX1 mRNA]; NFE2L2 mRNA promotes the reaction [cinnamaldehyde results in increased expression of HMOX1 mRNA]; pyrazolanthrone inhibits the reaction [cinnamaldehyde results in increased expression of HMOX1 protein] cinnamaldehyde analog results in increased expression of HMOX1 mRNA; cinnamaldehyde analog results in increased expression of HMOX1 protein; cinnamaldehyde results in increased expression of HMOX1 mRNA; cinnamaldehyde results in increased expression of HMOX1 protein |
CTD |
PMID:17178418 PMID:18304597 PMID:18482591 PMID:19000754 PMID:19033392 PMID:20713136 PMID:21469739 PMID:24211530 PMID:25724174 PMID:26244607 PMID:28219650 PMID:30806763 PMID:31187328 More...
|
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HNRNPK |
heterogeneous nuclear ribonucleoprotein K |
increases metabolic processing |
EXP |
cinnamaldehyde results in increased metabolism of HNRNPK protein |
CTD |
PMID:29267982 |
|
NCBI chr 9:83,968,083...83,980,615
Ensembl chr 9:83,968,083...83,980,631
|
|
G |
HPRT1 |
hypoxanthine phosphoribosyltransferase 1 |
decreases mutagenesis |
EXP |
cinnamaldehyde results in decreased mutagenesis of HPRT1 gene |
CTD |
PMID:17178418 |
|
NCBI chr X:134,460,165...134,500,668
Ensembl chr X:134,460,165...134,520,513
|
|
G |
HSP90AA1 |
heat shock protein 90 alpha family class A member 1 |
increases metabolic processing |
EXP |
cinnamaldehyde results in increased metabolism of HSP90AA1 protein |
CTD |
PMID:29267982 |
|
NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
|
|
G |
HSPA1B |
heat shock protein family A (Hsp70) member 1B |
increases expression |
EXP |
cinnamaldehyde results in increased expression of HSPA1B mRNA |
CTD |
PMID:17178418 |
|
NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254
|
|
G |
HSPA6 |
heat shock protein family A (Hsp70) member 6 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of HSPA6 mRNA |
CTD |
PMID:23999411 |
|
NCBI chr 1:161,524,540...161,526,894
Ensembl chr 1:161,524,540...161,526,894
|
|
G |
HSPA8 |
heat shock protein family A (Hsp70) member 8 |
increases metabolic processing |
EXP |
cinnamaldehyde results in increased metabolism of HSPA8 protein |
CTD |
PMID:29267982 |
|
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
|
|
G |
HSPH1 |
heat shock protein family H (Hsp110) member 1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of HSPH1 mRNA |
CTD |
PMID:23999411 |
|
NCBI chr13:31,134,973...31,162,388
Ensembl chr13:31,134,973...31,162,388
|
|
G |
HTATIP2 |
HIV-1 Tat interactive protein 2 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of HTATIP2 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr11:20,363,714...20,383,782
Ensembl chr11:20,363,685...20,383,782
|
|
G |
HTRA2 |
HtrA serine peptidase 2 |
affects localization multiple interactions |
EXP |
cinnamaldehyde affects the localization of HTRA2 protein Vitamin E inhibits the reaction [cinnamaldehyde affects the localization of HTRA2 protein] |
CTD |
PMID:15566391 |
|
NCBI chr 2:74,529,405...74,533,556
Ensembl chr 2:74,529,596...74,533,350
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
increases expression multiple interactions |
EXP ISO |
cinnamaldehyde results in increased expression of ICAM1 mRNA; cinnamaldehyde results in increased expression of ICAM1 protein cinnamaldehyde inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ICAM1 protein] [cinnamaldehyde results in increased activity of GLRX protein] inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; [cinnamaldehyde results in increased activity of NFE2L2 protein] inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; Buthionine Sulfoximine inhibits the reaction [cinnamaldehyde inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]; cinnamaldehyde inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] |
CTD |
PMID:20351055 PMID:30806763 PMID:33522063 |
|
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
IFI27 |
interferon alpha inducible protein 27 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of IFI27 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr14:94,105,894...94,116,690
Ensembl chr14:94,104,836...94,116,695
|
|
G |
IFI44L |
interferon induced protein 44 like |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of IFI44L mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 1:78,620,448...78,646,145
Ensembl chr 1:78,619,902...78,646,145
|
|
G |
IFNB1 |
interferon beta 1 |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA] |
CTD |
PMID:17920563 |
|
NCBI chr 9:21,077,104...21,077,942
Ensembl chr 9:21,077,104...21,077,942
|
|
G |
IFNG |
interferon gamma |
increases expression affects expression |
ISO |
cinnamaldehyde results in increased expression of IFNG protein cinnamaldehyde affects the expression of IFNG mRNA |
CTD |
PMID:11244134 PMID:28219650 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IKBKB |
inhibitor of nuclear factor kappa B kinase subunit beta |
decreases phosphorylation |
ISO |
cinnamaldehyde results in decreased phosphorylation of IKBKB protein |
CTD |
PMID:17486422 |
|
NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460
|
|
G |
IL10 |
interleukin 10 |
affects expression |
ISO |
cinnamaldehyde affects the expression of IL10 mRNA |
CTD |
PMID:28219650 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL12A |
interleukin 12A |
affects expression multiple interactions |
ISO |
cinnamaldehyde affects the expression of IL12A mRNA NFE2L2 protein inhibits the reaction [cinnamaldehyde results in increased expression of IL12A mRNA] |
CTD |
PMID:28219650 |
|
NCBI chr 3:159,988,835...159,996,019
Ensembl chr 3:159,988,835...159,996,019
|
|
G |
IL12B |
interleukin 12B |
decreases expression |
ISO |
cinnamaldehyde results in decreased expression of IL12B mRNA |
CTD |
PMID:28219650 |
|
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
|
|
G |
IL16 |
interleukin 16 |
increases secretion multiple interactions |
EXP |
cinnamaldehyde results in increased secretion of IL16 protein cinnamaldehyde results in increased expression of and results in increased secretion of IL16 protein |
CTD |
PMID:23624239 PMID:30806763 |
|
NCBI chr15:81,182,712...81,314,058
Ensembl chr15:81,159,575...81,314,058
|
|
G |
IL18 |
interleukin 18 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of IL18 mRNA; cinnamaldehyde results in increased expression of IL18 protein |
CTD |
PMID:23063874 PMID:30806763 |
|
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
|
|
G |
IL1A |
interleukin 1 alpha |
increases expression |
EXP ISO |
cinnamaldehyde results in increased expression of IL1A mRNA |
CTD |
PMID:25290854 PMID:28219650 PMID:30806763 PMID:33715048 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions increases expression |
EXP ISO |
cinnamaldehyde inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL1B protein] cinnamaldehyde inhibits the reaction [IL1B protein results in increased abundance of Dinoprostone]; cinnamaldehyde inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]; cinnamaldehyde inhibits the reaction [Testosterone results in increased expression of IL1B protein] cinnamaldehyde inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; NFE2L2 protein inhibits the reaction [cinnamaldehyde results in increased expression of IL1B mRNA] |
CTD |
PMID:16624280 PMID:19524605 PMID:20467561 PMID:21807015 PMID:28219650 PMID:32628957 PMID:33715048 More...
|
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein] cinnamaldehyde inhibits the reaction [Testosterone results in increased expression of IL6 protein]; cinnamaldehyde inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 protein] |
CTD |
PMID:17868967 PMID:32628957 PMID:33522063 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
IL7R |
interleukin 7 receptor |
increases expression |
EXP |
cinnamaldehyde results in increased expression of IL7R mRNA |
CTD |
PMID:20713136 |
|
NCBI chr 5:35,856,891...35,879,603
Ensembl chr 5:35,852,695...35,879,603
|
|
G |
INSIG1 |
insulin induced gene 1 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of INSIG1 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235
|
|
G |
IRF3 |
interferon regulatory factor 3 |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [Lipopolysaccharides results in increased activity of IRF3 protein] |
CTD |
PMID:17920563 |
|
NCBI chr19:49,659,572...49,665,857
Ensembl chr19:49,659,569...49,665,875
|
|
G |
ITGA11 |
integrin subunit alpha 11 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of ITGA11 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr15:68,296,532...68,432,163
Ensembl chr15:68,296,532...68,432,163
|
|
G |
JAK1 |
Janus kinase 1 |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [Testosterone results in increased expression of JAK1 protein] |
CTD |
PMID:32628957 |
|
NCBI chr 1:64,833,229...65,067,746
Ensembl chr 1:64,833,223...65,067,754
|
|
G |
JAK2 |
Janus kinase 2 |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of JAK2 protein] |
CTD |
PMID:33522063 |
|
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
EXP |
cinnamaldehyde analog results in decreased expression of JUN protein |
CTD |
PMID:17510524 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
JUND |
JunD proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of JUND mRNA |
CTD |
PMID:17178418 |
|
NCBI chr19:18,279,694...18,281,622
Ensembl chr19:18,279,694...18,281,622
|
|
G |
KEAP1 |
kelch like ECH associated protein 1 |
affects expression increases expression |
ISO EXP |
cinnamaldehyde affects the expression of KEAP1 mRNA cinnamaldehyde results in increased expression of KEAP1 protein |
CTD |
PMID:19033392 PMID:28219650 |
|
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
|
|
G |
LHFPL6 |
LHFPL tetraspan subfamily member 6 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of LHFPL6 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr13:39,342,892...39,603,193
Ensembl chr13:39,209,116...39,603,528
|
|
G |
LMCD1 |
LIM and cysteine rich domains 1 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of LMCD1 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 3:8,501,823...8,574,668
Ensembl chr 3:8,501,807...8,574,668
|
|
G |
LMNA |
lamin A/C |
increases metabolic processing |
EXP |
cinnamaldehyde results in increased metabolism of LMNA protein |
CTD |
PMID:29267982 |
|
NCBI chr 1:156,082,573...156,140,081
Ensembl chr 1:156,082,572...156,140,081
|
|
G |
LPL |
lipoprotein lipase |
decreases expression |
ISO |
cinnamaldehyde results in decreased expression of LPL mRNA |
CTD |
PMID:21401097 |
|
NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
|
|
G |
LRP12 |
LDL receptor related protein 12 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of LRP12 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 8:104,489,236...104,589,258
Ensembl chr 8:104,489,231...104,589,258
|
|
G |
LTA |
lymphotoxin alpha |
increases expression |
EXP |
cinnamaldehyde results in increased expression of LTA mRNA |
CTD |
PMID:19000754 |
|
NCBI chr 6:31,560,610...31,574,324
Ensembl chr 6:31,572,054...31,574,324
|
|
G |
MAGIX |
MAGI family member, X-linked |
increases expression |
EXP |
cinnamaldehyde results in increased expression of MAGIX mRNA |
CTD |
PMID:19524605 |
|
NCBI chr X:49,162,665...49,168,774
Ensembl chr X:49,162,564...49,168,774
|
|
G |
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of MAP2K2 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr19:4,090,321...4,124,122
Ensembl chr19:4,090,321...4,124,122
|
|
G |
MAP3K14 |
mitogen-activated protein kinase kinase kinase 14 |
decreases phosphorylation |
ISO |
cinnamaldehyde results in decreased phosphorylation of MAP3K14 protein |
CTD |
PMID:17486422 |
|
NCBI chr17:45,263,119...45,317,020
Ensembl chr17:45,263,119...45,317,029
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions decreases phosphorylation |
ISO EXP |
cinnamaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK1 protein] cinnamaldehyde results in increased phosphorylation of and results in increased activity of MAPK1 protein cinnamaldehyde inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] cinnamaldehyde results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:15964311 PMID:17486422 PMID:17868967 PMID:20060012 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK14 |
mitogen-activated protein kinase 14 |
decreases phosphorylation multiple interactions |
ISO EXP |
cinnamaldehyde results in decreased phosphorylation of MAPK14 protein cinnamaldehyde results in increased phosphorylation of and results in increased activity of MAPK14 protein; pyrazolanthrone inhibits the reaction [cinnamaldehyde results in increased phosphorylation of MAPK14 protein]; SB 203580 inhibits the reaction [cinnamaldehyde results in increased phosphorylation of MAPK14 protein] |
CTD |
PMID:15964311 PMID:17486422 |
|
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
decreases phosphorylation multiple interactions |
ISO EXP |
cinnamaldehyde results in decreased phosphorylation of MAPK3 protein cinnamaldehyde inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein] cinnamaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK3 protein] cinnamaldehyde results in increased phosphorylation of and results in increased activity of MAPK3 protein |
CTD |
PMID:15964311 PMID:17486422 PMID:17868967 PMID:20060012 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
increases phosphorylation multiple interactions |
EXP ISO |
cinnamaldehyde results in increased phosphorylation of MAPK8 protein cinnamaldehyde results in increased phosphorylation of and results in increased activity of MAPK8 protein; pyrazolanthrone inhibits the reaction [cinnamaldehyde results in increased phosphorylation of MAPK8 protein]; SB 203580 inhibits the reaction [cinnamaldehyde results in increased phosphorylation of MAPK8 protein] cinnamaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:15964311 PMID:17868967 PMID:21469739 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MAPK9 |
mitogen-activated protein kinase 9 |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK9 protein] |
CTD |
PMID:17868967 |
|
NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
|
|
G |
MAPKAPK5 |
MAPK activated protein kinase 5 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of MAPKAPK5 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr12:111,842,228...111,902,222
Ensembl chr12:111,842,013...111,902,222
|
|
G |
MARK4 |
microtubule affinity regulating kinase 4 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of MARK4 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr19:45,251,271...45,305,284
Ensembl chr19:45,079,288...45,305,284
|
|
G |
MCL1 |
MCL1 apoptosis regulator, BCL2 family member |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of MCL1 protein |
CTD |
PMID:15964311 |
|
NCBI chr 1:150,574,558...150,579,610
Ensembl chr 1:150,560,895...150,579,738
|
|
G |
MDM2 |
MDM2 proto-oncogene |
increases expression |
EXP |
cinnamaldehyde results in increased expression of MDM2 mRNA |
CTD |
PMID:19000754 |
|
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
|
|
G |
MIF |
macrophage migration inhibitory factor |
increases expression |
ISO |
cinnamaldehyde results in increased expression of MIF mRNA |
CTD |
PMID:11244134 |
|
NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP |
cinnamaldehyde inhibits the reaction [TGFB1 protein results in increased expression of MMP2 protein] |
CTD |
PMID:28258635 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP3 |
matrix metallopeptidase 3 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of MMP3 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
|
|
G |
MPO |
myeloperoxidase |
multiple interactions increases activity |
ISO |
2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [cinnamaldehyde results in increased activity of MPO protein]; Camphor inhibits the reaction [cinnamaldehyde results in increased activity of MPO protein]; Ruthenium Red inhibits the reaction [cinnamaldehyde results in increased activity of MPO protein] cinnamaldehyde inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein] |
CTD |
PMID:21466812 PMID:33522063 |
|
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
MX1 |
MX dynamin like GTPase 1 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of MX1 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr21:41,420,558...41,459,214
Ensembl chr21:41,420,020...41,470,071
|
|
G |
MYC |
MYC proto-oncogene, bHLH transcription factor |
increases expression decreases expression |
EXP |
cinnamaldehyde results in increased expression of MYC mRNA cinnamaldehyde results in decreased expression of MYC protein |
CTD |
PMID:21729535 PMID:24211530 |
|
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
|
|
G |
MYD88 |
MYD88 innate immune signal transduction adaptor |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 mRNA]; cinnamaldehyde inhibits the reaction [Poly I-C results in increased expression of MYD88 mRNA] |
CTD |
PMID:18306459 |
|
NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024
|
|
G |
NBPF10 |
NBPF member 10 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of NBPF10 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 1:146,064,699...146,144,804
Ensembl chr 1:146,064,711...146,229,000
|
|
G |
NCF1 |
neutrophil cytosolic factor 1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of NCF1 mRNA |
CTD |
PMID:19000754 |
|
NCBI chr 7:74,774,011...74,789,315
Ensembl chr 7:74,774,011...74,789,315
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
affects localization increases activity multiple interactions affects response to substance affects expression increases expression |
EXP ISO |
cinnamaldehyde affects the localization of NFE2L2 protein cinnamaldehyde results in increased activity of NFE2L2 protein cinnamaldehyde inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NFE2L2 protein]; NFE2L2 protein inhibits the reaction [cinnamaldehyde results in decreased abundance of Glutathione]; NFE2L2 protein inhibits the reaction [cinnamaldehyde results in increased abundance of Reactive Oxygen Species]; NFE2L2 protein inhibits the reaction [cinnamaldehyde results in increased expression of CCL3 mRNA]; NFE2L2 protein inhibits the reaction [cinnamaldehyde results in increased expression of CXCL1 mRNA]; NFE2L2 protein inhibits the reaction [cinnamaldehyde results in increased expression of CXCL10 mRNA]; NFE2L2 protein inhibits the reaction [cinnamaldehyde results in increased expression of IL12A mRNA]; NFE2L2 protein inhibits the reaction [cinnamaldehyde results in increased expression of IL1B mRNA]; NFE2L2 protein promotes the reaction [cinnamaldehyde results in increased expression of CAT mRNA]; NFE2L2 protein promotes the reaction [cinnamaldehyde results in increased expression of GPX1 mRNA]; NFE2L2 protein promotes the reaction [cinnamaldehyde results in increased expression of GPX2 mRNA]; NFE2L2 protein promotes the reaction [cinnamaldehyde results in increased expression of GPX5 mRNA]; NFE2L2 protein promotes the reaction [cinnamaldehyde results in increased expression of GPX6 mRNA]; NFE2L2 protein promotes the reaction [cinnamaldehyde results in increased expression of GSR mRNA]; NFE2L2 protein promotes the reaction [cinnamaldehyde results in increased expression of NOS2 mRNA] NFE2L2 affects the susceptibility to cinnamaldehyde [cinnamaldehyde results in increased activity of NFE2L2 protein] inhibits the reaction [TNF protein affects the localization of RELA protein]; [cinnamaldehyde results in increased activity of NFE2L2 protein] inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; [cinnamaldehyde results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA; [cinnamaldehyde results in increased activity of NFE2L2 protein] which results in increased expression of GCLM mRNA; [cinnamaldehyde results in increased activity of NFE2L2 protein] which results in increased glutathionylation of RELA protein; cinnamaldehyde results in increased expression of and results in increased activity of NFE2L2 protein; NFE2L2 mRNA affects the reaction [cinnamaldehyde results in increased expression of GCLC protein]; NFE2L2 mRNA promotes the reaction [cinnamaldehyde results in increased expression of AKR1C2 mRNA]; NFE2L2 mRNA promotes the reaction [cinnamaldehyde results in increased expression of HMOX1 mRNA] cinnamaldehyde affects the expression of NFE2L2 protein cinnamaldehyde analog results in increased expression of NFE2L2 protein; cinnamaldehyde results in increased expression of NFE2L2 protein |
CTD |
PMID:18304597 PMID:18482591 PMID:19033392 PMID:20351055 PMID:21469739 PMID:23564646 PMID:26244607 PMID:28219650 PMID:30806763 PMID:31187328 More...
|
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
decreases expression |
EXP ISO |
cinnamaldehyde results in decreased expression of NFKB1 mRNA cinnamaldehyde results in decreased expression of NFKB1 protein |
CTD |
PMID:17486422 PMID:20385217 PMID:28219650 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:20467561 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NINL |
ninein like |
increases expression |
EXP |
cinnamaldehyde results in increased expression of NINL mRNA |
CTD |
PMID:19524605 |
|
NCBI chr20:25,452,697...25,585,531
Ensembl chr20:25,451,594...25,585,531
|
|
G |
NOS2 |
nitric oxide synthase 2 |
affects expression decreases expression multiple interactions |
ISO |
cinnamaldehyde affects the expression of NOS2 mRNA cinnamaldehyde results in decreased expression of NOS2 protein cinnamaldehyde inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; NFE2L2 protein promotes the reaction [cinnamaldehyde results in increased expression of NOS2 mRNA] |
CTD |
PMID:17486422 PMID:20467561 PMID:28219650 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOTCH3 |
notch receptor 3 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of NOTCH3 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr19:15,159,038...15,200,995
Ensembl chr19:15,159,038...15,200,995
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
increases activity increases expression |
EXP ISO |
cinnamaldehyde results in increased activity of NQO1 protein cinnamaldehyde analog results in increased expression of NQO1 mRNA; cinnamaldehyde results in increased expression of NQO1 mRNA |
CTD |
PMID:18482591 PMID:19033392 PMID:19524605 PMID:24211530 PMID:28219650 PMID:30806763 More...
|
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
NRF1 |
nuclear respiratory factor 1 |
decreases expression |
ISO |
cinnamaldehyde results in decreased expression of NRF1 mRNA |
CTD |
PMID:28219650 |
|
NCBI chr 7:129,611,720...129,757,076
Ensembl chr 7:129,611,720...129,757,082
|
|
G |
PANX2 |
pannexin 2 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of PANX2 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr22:50,170,731...50,180,295
Ensembl chr22:50,170,731...50,180,295
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
increases cleavage |
EXP |
cinnamaldehyde analog results in increased cleavage of PARP1 protein |
CTD |
PMID:16343908 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PCK1 |
phosphoenolpyruvate carboxykinase 1 |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [Streptozocin results in increased expression of PCK1 mRNA] |
CTD |
PMID:20363216 |
|
NCBI chr20:57,561,110...57,568,121
Ensembl chr20:57,561,080...57,568,121
|
|
G |
PDE3B |
phosphodiesterase 3B |
increases expression |
EXP |
cinnamaldehyde results in increased expression of PDE3B mRNA |
CTD |
PMID:19524605 |
|
NCBI chr11:14,643,804...14,872,044 NCBI chr11:14,887,823...14,899,321
Ensembl chr11:14,643,804...14,872,044
|
|
G |
PDK1 |
pyruvate dehydrogenase kinase 1 |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of PDK1 protein] |
CTD |
PMID:20467561 |
|
NCBI chr 2:172,555,373...172,724,312
Ensembl chr 2:172,555,373...172,608,669
|
|
G |
PHLDA2 |
pleckstrin homology like domain family A member 2 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of PHLDA2 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr11:2,928,273...2,929,420
Ensembl chr11:2,928,273...2,929,420
|
|
G |
PIR |
pirin |
increases expression |
EXP |
cinnamaldehyde results in increased expression of PIR mRNA |
CTD |
PMID:19524605 |
|
NCBI chr X:15,384,799...15,493,333
Ensembl chr X:15,384,799...15,493,564
|
|
G |
PKLR |
pyruvate kinase L/R |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [Streptozocin results in decreased expression of PKLR mRNA] |
CTD |
PMID:20363216 |
|
NCBI chr 1:155,289,293...155,308,654
Ensembl chr 1:155,289,293...155,301,438
|
|
G |
PKM |
pyruvate kinase M1/2 |
increases metabolic processing |
EXP |
cinnamaldehyde results in increased metabolism of PKM protein |
CTD |
PMID:29267982 |
|
NCBI chr15:72,199,029...72,231,591
Ensembl chr15:72,199,029...72,231,819
|
|
G |
PLAU |
plasminogen activator, urokinase |
multiple interactions |
EXP |
cinnamaldehyde inhibits the reaction [TGFB1 protein results in increased expression of PLAU protein] |
CTD |
PMID:28258635 |
|
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
|
|
G |
PMAIP1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of PMAIP1 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr18:59,899,996...59,904,305
Ensembl chr18:59,899,996...59,904,305
|
|
G |
POR |
cytochrome p450 oxidoreductase |
increases expression |
EXP |
cinnamaldehyde results in increased expression of POR mRNA |
CTD |
PMID:19000754 |
|
NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
decreases expression |
ISO |
cinnamaldehyde results in decreased expression of PPARG mRNA |
CTD |
PMID:21401097 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PPBP |
pro-platelet basic protein |
increases expression multiple interactions |
EXP |
cinnamaldehyde results in increased expression of PPBP mRNA cinnamaldehyde results in increased expression of and results in increased secretion of PPBP protein |
CTD |
PMID:23624239 |
|
NCBI chr 4:73,986,439...73,988,190
Ensembl chr 4:73,986,439...73,988,190
|
|
G |
PPFIBP1 |
PPFIA binding protein 1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of PPFIBP1 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr12:27,524,206...27,695,564
Ensembl chr12:27,523,431...27,695,564
|
|
G |
PPP1R10 |
protein phosphatase 1 regulatory subunit 10 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of PPP1R10 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr 6:30,600,413...30,617,243
Ensembl chr 6:30,600,413...30,618,612
|
|
G |
PRDM5 |
PR/SET domain 5 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of PRDM5 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 4:120,684,291...120,922,726
Ensembl chr 4:120,684,919...120,922,870
|
|
G |
PTGR1 |
prostaglandin reductase 1 |
multiple interactions |
ISO |
[PTGR1 protein co-treated with NADP] affects the reduction of cinnamaldehyde |
CTD |
PMID:11524419 |
|
NCBI chr 9:111,549,722...111,599,647
Ensembl chr 9:111,549,722...111,599,893
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression decreases expression |
ISO EXP |
cinnamaldehyde inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein] cinnamaldehyde inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 mRNA]; cinnamaldehyde inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein] cinnamaldehyde results in increased expression of PTGS2 mRNA cinnamaldehyde inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] cinnamaldehyde results in decreased expression of PTGS2 protein |
CTD |
PMID:16624280 PMID:17486422 PMID:17920563 PMID:21807015 PMID:30806763 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RAC1 |
Rac family small GTPase 1 |
decreases expression |
ISO |
cinnamaldehyde results in decreased expression of RAC1 protein |
CTD |
PMID:17486422 |
|
NCBI chr 7:6,374,527...6,403,967
Ensembl chr 7:6,374,527...6,403,967
|
|
G |
RBP4 |
retinol binding protein 4 |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased secretion of RBP4 protein] |
CTD |
PMID:19080170 |
|
NCBI chr10:93,591,694...93,601,744
Ensembl chr10:93,591,687...93,601,744
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions increases glutathionylation decreases expression |
EXP ISO |
[Buthionine Sulfoximine results in decreased abundance of Glutathione] inhibits the reaction [cinnamaldehyde results in increased glutathionylation of RELA protein]; [Cadmium Chloride affects the activity of GLRX protein] inhibits the reaction [cinnamaldehyde results in increased glutathionylation of RELA protein]; [cinnamaldehyde results in increased abundance of Glutathione] which results in increased glutathionylation of RELA protein; [cinnamaldehyde results in increased abundance of Hydrogen Peroxide] which results in increased glutathionylation of RELA protein; [cinnamaldehyde results in increased activity of GLRX protein] inhibits the reaction [TNF protein affects the localization of RELA protein]; [cinnamaldehyde results in increased activity of GLRX protein] which results in increased glutathionylation of RELA protein; [cinnamaldehyde results in increased activity of NFE2L2 protein] inhibits the reaction [TNF protein affects the localization of RELA protein]; [cinnamaldehyde results in increased activity of NFE2L2 protein] which results in increased glutathionylation of RELA protein; Buthionine Sulfoximine inhibits the reaction [cinnamaldehyde inhibits the reaction [TNF protein affects the localization of RELA protein]]; cinnamaldehyde inhibits the reaction [TNF protein affects the localization of RELA protein]; Dithiothreitol inhibits the reaction [cinnamaldehyde results in increased glutathionylation of RELA protein] cinnamaldehyde inhibits the reaction [Testosterone results in increased expression of RELA protein] cinnamaldehyde results in decreased expression of RELA protein |
CTD |
PMID:17486422 PMID:20351055 PMID:32628957 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
RTN4RL1 |
reticulon 4 receptor like 1 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of RTN4RL1 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr17:1,934,677...2,025,334
Ensembl chr17:1,934,677...2,025,334
|
|
G |
SEL1L3 |
SEL1L family member 3 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of SEL1L3 mRNA |
CTD |
PMID:24211530 |
|
NCBI chr 4:25,713,964...25,863,566
Ensembl chr 4:25,747,433...25,863,760
|
|
G |
SERPINB3 |
serpin family B member 3 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of SERPINB3 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr18:63,655,197...63,661,893
Ensembl chr18:63,655,197...63,661,893
|
|
G |
SERPINE1 |
serpin family E member 1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of SERPINE1 mRNA |
CTD |
PMID:19000754 |
|
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
|
|
G |
SGCD |
sarcoglycan delta |
increases expression |
EXP |
cinnamaldehyde results in increased expression of SGCD mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 5:155,727,832...156,767,788
Ensembl chr 5:155,870,344...156,767,788
|
|
G |
SLC14A1 |
solute carrier family 14 member 1 (Kidd blood group) |
increases expression |
EXP |
cinnamaldehyde results in increased expression of SLC14A1 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr18:45,724,181...45,752,520
Ensembl chr18:45,687,025...45,752,520
|
|
G |
SLC1A2 |
solute carrier family 1 member 2 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of SLC1A2 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr11:35,251,205...35,420,507
Ensembl chr11:35,251,205...35,420,063
|
|
G |
SLC26A7 |
solute carrier family 26 member 7 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of SLC26A7 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 8:91,209,496...91,398,155
Ensembl chr 8:91,209,494...91,398,155
|
|
G |
SLC2A1 |
solute carrier family 2 member 1 |
multiple interactions increases activity |
ISO |
[cinnamaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein; Cysteine inhibits the reaction [[cinnamaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein]; Mercaptoethanol inhibits the reaction [[cinnamaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein] cinnamaldehyde results in increased activity of SLC2A1 protein |
CTD |
PMID:20955755 |
|
NCBI chr 1:42,925,353...42,958,868
Ensembl chr 1:42,925,353...42,958,893
|
|
G |
SLC2A13 |
solute carrier family 2 member 13 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of SLC2A13 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr12:39,755,025...40,106,081
Ensembl chr12:39,755,025...40,106,089
|
|
G |
SLC2A4 |
solute carrier family 2 member 4 |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of SLC2A4 protein]; cinnamaldehyde inhibits the reaction [Streptozocin affects the localization of SLC2A4 protein] |
CTD |
PMID:19080170 PMID:20363216 |
|
NCBI chr17:7,281,718...7,288,257
Ensembl chr17:7,281,718...7,288,257
|
|
G |
SLC35D2 |
solute carrier family 35 member D2 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of SLC35D2 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr 9:96,313,444...96,383,711
Ensembl chr 9:96,313,444...96,383,711
|
|
G |
SLC7A11 |
solute carrier family 7 member 11 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of SLC7A11 mRNA |
CTD |
PMID:17178418 PMID:24211530 PMID:30806763 |
|
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
|
|
G |
SLC8A1 |
solute carrier family 8 member A1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of SLC8A1 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 2:40,097,270...40,512,435
Ensembl chr 2:40,097,270...40,611,053
|
|
G |
SMAD2 |
SMAD family member 2 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of SMAD2 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr18:47,808,957...47,930,872
Ensembl chr18:47,808,957...47,931,146
|
|
G |
SNCA |
synuclein alpha |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of SNCA protein] |
CTD |
PMID:31187328 |
|
NCBI chr 4:89,724,099...89,838,304
Ensembl chr 4:89,700,345...89,838,315
|
|
G |
SNX24 |
sorting nexin 24 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of SNX24 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 5:122,845,613...123,029,318
Ensembl chr 5:122,843,439...123,029,354
|
|
G |
SOCS3 |
suppressor of cytokine signaling 3 |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of SOCS3 protein] |
CTD |
PMID:33522063 |
|
NCBI chr17:78,356,778...78,360,925
Ensembl chr17:78,356,778...78,360,077
|
|
G |
SOD2 |
superoxide dismutase 2 |
decreases expression |
ISO |
cinnamaldehyde results in decreased expression of SOD2 mRNA |
CTD |
PMID:28219650 |
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
|
|
G |
SQSTM1 |
sequestosome 1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of SQSTM1 mRNA |
CTD |
PMID:24211530 |
|
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
|
|
G |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions decreases expression |
ISO |
dorsomorphin inhibits the reaction [cinnamaldehyde results in decreased expression of SREBF1 mRNA] |
CTD |
PMID:21401097 |
|
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
|
|
G |
SRSF11 |
serine and arginine rich splicing factor 11 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of SRSF11 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 1:70,205,696...70,253,052
Ensembl chr 1:70,205,682...70,253,052
|
|
G |
SRXN1 |
sulfiredoxin 1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of SRXN1 mRNA |
CTD |
PMID:19000754 |
|
NCBI chr20:646,615...653,200
Ensembl chr20:646,615...653,200
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [Testosterone results in increased expression of STAT3 protein modified form]; cinnamaldehyde inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of STAT3 protein] |
CTD |
PMID:32628957 PMID:33522063 |
|
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
|
|
G |
STAU2 |
staufen double-stranded RNA binding protein 2 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of STAU2 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 8:73,420,369...73,747,480
Ensembl chr 8:73,420,369...73,747,708
|
|
G |
STK24 |
serine/threonine kinase 24 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of STK24 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr13:98,445,185...98,577,107
Ensembl chr13:98,445,185...98,577,940
|
|
G |
SUFU |
SUFU negative regulator of hedgehog signaling |
increases expression |
EXP |
cinnamaldehyde results in increased expression of SUFU mRNA |
CTD |
PMID:19524605 |
|
NCBI chr10:102,502,819...102,633,535
Ensembl chr10:102,503,972...102,633,535
|
|
G |
SYNE2 |
spectrin repeat containing nuclear envelope protein 2 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of SYNE2 mRNA |
CTD |
PMID:24211530 |
|
NCBI chr14:63,761,596...64,226,449
Ensembl chr14:63,761,899...64,226,433
|
|
G |
TBXA2R |
thromboxane A2 receptor |
multiple interactions |
EXP |
cinnamaldehyde binds to and results in decreased activity of TBXA2R protein |
CTD |
PMID:17079160 |
|
NCBI chr19:3,594,507...3,606,875
Ensembl chr19:3,594,507...3,606,875
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions increases expression |
EXP ISO |
cinnamaldehyde inhibits the reaction [TGFB1 protein results in increased expression of MMP2 protein]; cinnamaldehyde inhibits the reaction [TGFB1 protein results in increased expression of PLAU protein] cinnamaldehyde results in increased expression of TGFB1 mRNA |
CTD |
PMID:11244134 PMID:28258635 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TGFB1I1 |
transforming growth factor beta 1 induced transcript 1 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of TGFB1I1 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr16:31,472,152...31,477,960
Ensembl chr16:31,471,585...31,477,960
|
|
G |
TH |
tyrosine hydroxylase |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of TH protein] |
CTD |
PMID:31187328 |
|
NCBI chr11:2,163,929...2,171,815
Ensembl chr11:2,163,929...2,171,815
|
|
G |
THNSL2 |
threonine synthase like 2 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of THNSL2 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 2:88,170,346...88,186,627
Ensembl chr 2:88,170,295...88,186,636
|
|
G |
TLR3 |
toll like receptor 3 |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [Poly I-C results in increased expression of TLR3 mRNA] |
CTD |
PMID:18306459 |
|
NCBI chr 4:186,069,156...186,088,073
Ensembl chr 4:186,068,911...186,088,073
|
|
G |
TLR4 |
toll like receptor 4 |
increases expression multiple interactions |
EXP ISO |
cinnamaldehyde results in increased expression of TLR4 mRNA cinnamaldehyde inhibits the reaction [Lipopolysaccharides promotes the reaction [TLR4 protein binds to TLR4 protein]]; cinnamaldehyde inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 mRNA] |
CTD |
PMID:17920563 PMID:18306459 PMID:19524605 |
|
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions increases expression |
ISO EXP |
cinnamaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNF protein]; cinnamaldehyde inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; cinnamaldehyde inhibits the reaction [lipoteichoic acid results in increased secretion of TNF protein] cinnamaldehyde inhibits the reaction [Testosterone results in increased expression of TNF protein]; cinnamaldehyde inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein] [cinnamaldehyde results in increased activity of GLRX protein] inhibits the reaction [TNF protein affects the localization of RELA protein]; [cinnamaldehyde results in increased activity of GLRX protein] inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; [cinnamaldehyde results in increased activity of NFE2L2 protein] inhibits the reaction [TNF protein affects the localization of RELA protein]; [cinnamaldehyde results in increased activity of NFE2L2 protein] inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; Buthionine Sulfoximine inhibits the reaction [cinnamaldehyde inhibits the reaction [TNF protein affects the localization of RELA protein]]; Buthionine Sulfoximine inhibits the reaction [cinnamaldehyde inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]; cinnamaldehyde inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein]; cinnamaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNF protein]; cinnamaldehyde inhibits the reaction [TNF protein affects the localization of RELA protein]; cinnamaldehyde inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] cinnamaldehyde results in increased expression of TNF mRNA |
CTD |
PMID:17868967 PMID:20351055 PMID:20385217 PMID:20467561 PMID:21807015 PMID:32628957 PMID:33522063 More...
|
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFRSF21 |
TNF receptor superfamily member 21 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of TNFRSF21 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 6:47,231,532...47,309,905
Ensembl chr 6:47,231,532...47,309,905
|
|
G |
TNNT2 |
troponin T2, cardiac type |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of TNNT2 mRNA |
CTD |
PMID:24211530 |
|
NCBI chr 1:201,359,014...201,377,680
Ensembl chr 1:201,359,008...201,377,764
|
|
G |
TP53 |
tumor protein p53 |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of TP53 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
|
|
G |
TRAF6 |
TNF receptor associated factor 6 |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [Lipopolysaccharides results in increased expression of TRAF6 mRNA] |
CTD |
PMID:18306459 |
|
NCBI chr11:36,483,769...36,510,272
Ensembl chr11:36,483,769...36,510,272
|
|
G |
TRIM16 |
tripartite motif containing 16 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of TRIM16 mRNA |
CTD |
PMID:17178418 PMID:19524605 |
|
NCBI chr17:15,627,966...15,684,311
Ensembl chr17:15,627,960...15,684,311
|
|
G |
TRIM16L |
tripartite motif containing 16 like (pseudogene) |
increases expression |
EXP |
cinnamaldehyde results in increased expression of TRIM16L mRNA |
CTD |
PMID:24211530 |
|
NCBI chr17:18,697,998...18,736,112
Ensembl chr17:18,722,237...18,735,460 Ensembl chr17:18,722,237...18,735,460
|
|
G |
TRPA1 |
transient receptor potential cation channel subfamily A member 1 |
increases activity affects response to substance increases response to substance multiple interactions |
ISO EXP |
cinnamaldehyde results in increased activity of TRPA1 protein TRPA1 mRNA affects the susceptibility to cinnamaldehyde TRPA1 protein results in increased susceptibility to cinnamaldehyde TRPA1 affects the susceptibility to cinnamaldehyde 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [cinnamaldehyde results in increased activity of TRPA1 protein]; 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [cinnamaldehyde results in increased activity of TRPA1 protein]; cinnamaldehyde binds to and results in increased activity of TRPA1 protein; isopentenyl pyrophosphate inhibits the reaction [cinnamaldehyde results in increased activity of TRPA1 protein]; Ruthenium Red inhibits the reaction [cinnamaldehyde results in increased activity of TRPA1 protein] 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [cinnamaldehyde results in increased activity of TRPA1 protein]; [cinnamaldehyde results in increased activity of TRPA1 protein] which results in increased transport of Calcium; edelfosine inhibits the reaction [F2RL1 protein promotes the reaction [cinnamaldehyde results in increased activity of TRPA1 protein]]; F2RL1 protein promotes the reaction [cinnamaldehyde results in increased activity of TRPA1 protein]; TRPA1 mRNA affects the reaction [cinnamaldehyde results in increased secretion of Serotonin]; TRPA1 mRNA affects the reaction [cinnamaldehyde results in increased uptake of Calcium] |
CTD |
PMID:15046718 PMID:17571167 PMID:17991581 PMID:19507004 PMID:20442136 PMID:20720158 PMID:21353389 PMID:21689654 PMID:22863862 PMID:22935519 PMID:27735854 More...
|
|
NCBI chr 8:72,021,250...72,090,010
Ensembl chr 8:72,019,917...72,075,584
|
|
G |
TRPV1 |
transient receptor potential cation channel subfamily V member 1 |
increases expression |
ISO |
cinnamaldehyde results in increased expression of TRPV1 mRNA |
CTD |
PMID:20390747 |
|
NCBI chr17:3,565,446...3,609,411
Ensembl chr17:3,565,444...3,609,411
|
|
G |
TTN |
titin |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of TTN mRNA |
CTD |
PMID:19000754 |
|
NCBI chr 2:178,525,989...178,807,423
Ensembl chr 2:178,525,989...178,830,802
|
|
G |
TXNRD1 |
thioredoxin reductase 1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of TXNRD1 mRNA; cinnamaldehyde results in increased expression of TXNRD1 protein |
CTD |
PMID:18304597 PMID:19000754 PMID:24211530 PMID:30806763 |
|
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
|
|
G |
TXNRD2 |
thioredoxin reductase 2 |
decreases expression |
ISO |
cinnamaldehyde results in decreased expression of TXNRD2 mRNA |
CTD |
PMID:28219650 |
|
NCBI chr22:19,875,522...19,941,818
Ensembl chr22:19,875,517...19,941,820
|
|
G |
UBE2D1 |
ubiquitin conjugating enzyme E2 D1 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of UBE2D1 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr10:58,335,006...58,370,748
Ensembl chr10:58,334,979...58,370,751
|
|
G |
UGP2 |
UDP-glucose pyrophosphorylase 2 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of UGP2 mRNA |
CTD |
PMID:17178418 |
|
NCBI chr 2:63,840,969...63,891,560
Ensembl chr 2:63,840,952...63,891,562
|
|
G |
UNG |
uracil DNA glycosylase |
decreases expression |
EXP |
cinnamaldehyde results in decreased expression of UNG mRNA |
CTD |
PMID:19000754 |
|
NCBI chr12:109,097,597...109,110,992
Ensembl chr12:109,097,597...109,126,725
|
|
G |
XDH |
xanthine dehydrogenase |
multiple interactions |
ISO |
cinnamaldehyde inhibits the reaction [Testosterone results in increased activity of XDH protein modified form] |
CTD |
PMID:32628957 |
|
NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742
|
|
G |
XIAP |
X-linked inhibitor of apoptosis |
decreases expression multiple interactions |
EXP |
cinnamaldehyde results in decreased expression of XIAP protein Vitamin E inhibits the reaction [cinnamaldehyde results in decreased expression of XIAP protein] |
CTD |
PMID:15566391 |
|
NCBI chr X:123,859,708...123,913,972
Ensembl chr X:123,859,712...123,913,972
|
|
G |
ZDHHC21 |
zinc finger DHHC-type palmitoyltransferase 21 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of ZDHHC21 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 9:14,588,797...14,693,432
Ensembl chr 9:14,611,071...14,693,432
|
|
G |
ZNF442 |
zinc finger protein 442 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of ZNF442 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr19:12,345,944...12,373,779
Ensembl chr19:12,345,944...12,365,905
|
|
G |
ZNF506 |
zinc finger protein 506 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of ZNF506 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr19:19,792,711...19,821,750
Ensembl chr19:19,785,839...19,821,751
|
|
G |
ZNF639 |
zinc finger protein 639 |
increases expression |
EXP |
cinnamaldehyde results in increased expression of ZNF639 mRNA |
CTD |
PMID:19524605 |
|
NCBI chr 3:179,322,876...179,338,583
Ensembl chr 3:179,323,031...179,338,583
|
|
|
G |
AICDA |
activation induced cytidine deaminase |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of AICDA mRNA |
CTD |
PMID:22302311 |
|
NCBI chr12:8,602,170...8,612,859
Ensembl chr12:8,602,155...8,613,242
|
|
G |
AKR1B1 |
aldo-keto reductase family 1 member B |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of AKR1B1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284
|
|
G |
AKR1B10 |
aldo-keto reductase family 1 member B10 |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of AKR1B10 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
|
|
G |
AKR1C1 |
aldo-keto reductase family 1 member C1 |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of AKR1C1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr10:4,963,415...4,983,283
Ensembl chr10:4,963,253...4,983,283
|
|
G |
AKR1C3 |
aldo-keto reductase family 1 member C3 |
increases expression affects expression |
EXP ISO |
hexyl cinnamic aldehyde results in increased expression of AKR1C3 mRNA hexyl cinnamic aldehyde affects the expression of AKR1C18 mRNA |
CTD |
PMID:20566472 PMID:22302311 |
|
NCBI chr10:5,048,781...5,107,686
Ensembl chr10:5,035,354...5,107,686
|
|
G |
ATF3 |
activating transcription factor 3 |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of ATF3 mRNA |
CTD |
PMID:27965148 |
|
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
|
|
G |
CAT |
catalase |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of CAT mRNA |
CTD |
PMID:20566472 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
increases secretion |
ISO |
hexyl cinnamic aldehyde results in increased secretion of CCL2 protein |
CTD |
PMID:22245253 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL4 |
C-C motif chemokine ligand 4 |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of CCL4 protein |
CTD |
PMID:18353026 |
|
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
|
|
G |
CCNA2 |
cyclin A2 |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of CCNA2 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
|
|
G |
CCNB1 |
cyclin B1 |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of CCNB1 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
|
|
G |
CCNE2 |
cyclin E2 |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of CCNE2 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 8:94,880,224...94,896,693
Ensembl chr 8:94,879,770...94,896,678
|
|
G |
CCR4 |
C-C motif chemokine receptor 4 |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of CCR4 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 3:32,951,644...32,956,349
Ensembl chr 3:32,951,644...32,956,349
|
|
G |
CCR7 |
C-C motif chemokine receptor 7 |
decreases expression |
EXP |
hexyl cinnamic aldehyde results in decreased expression of CCR7 protein |
CTD |
PMID:37326882 |
|
NCBI chr17:40,553,769...40,565,472
Ensembl chr17:40,553,769...40,565,472
|
|
G |
CD160 |
CD160 molecule |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of CD160 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 1:145,719,499...145,739,288
Ensembl chr 1:145,719,471...145,739,288
|
|
G |
CD207 |
CD207 molecule |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of CD207 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 2:70,824,130...70,835,816
Ensembl chr 2:70,830,211...70,835,816
|
|
G |
CD5L |
CD5 molecule like |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of CD5L mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 1:157,827,068...157,841,808
Ensembl chr 1:157,830,911...157,898,256
|
|
G |
CD80 |
CD80 molecule |
multiple interactions increases expression |
EXP |
[hexyl cinnamic aldehyde co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD80 protein hexyl cinnamic aldehyde results in increased expression of CD80 protein |
CTD |
PMID:31958493 |
|
NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
|
|
G |
CD83 |
CD83 molecule |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of CD83 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 6:14,117,256...14,136,918
Ensembl chr 6:14,117,256...14,136,918
|
|
G |
CD86 |
CD86 molecule |
multiple interactions increases expression |
EXP |
[hexyl cinnamic aldehyde co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD86 protein; PRKCB protein affects the reaction [hexyl cinnamic aldehyde results in increased expression of CD86 protein] |
CTD |
PMID:31958493 PMID:37326882 |
|
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
|
|
G |
CDC20 |
cell division cycle 20 |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of CDC20 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 1:43,358,981...43,363,203
Ensembl chr 1:43,358,981...43,363,203
|
|
G |
CDC25C |
cell division cycle 25C |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of CDC25C mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 5:138,285,265...138,338,355
Ensembl chr 5:138,285,269...138,338,355
|
|
G |
CDK1 |
cyclin dependent kinase 1 |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of CDK1 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
|
|
G |
CPHXL2 |
cytoplasmic polyadenylated homeobox like 2 |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of CPHX1 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr16:75,660,227...75,677,009
Ensembl chr16:75,660,227...75,677,009 Ensembl chr16:75,660,227...75,677,009
|
|
G |
CTLA4 |
cytotoxic T-lymphocyte associated protein 4 |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of CTLA4 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
increases expression |
ISO |
hexyl cinnamic aldehyde results in increased expression of CXCL1 mRNA |
CTD |
PMID:28826779 |
|
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CXCL14 |
C-X-C motif chemokine ligand 14 |
decreases expression |
EXP |
hexyl cinnamic aldehyde results in decreased expression of CXCL14 protein |
CTD |
PMID:31734321 |
|
NCBI chr 5:135,570,679...135,578,991
Ensembl chr 5:135,570,679...135,579,279
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
increases expression decreases expression |
ISO |
hexyl cinnamic aldehyde results in increased expression of CXCL2 mRNA; hexyl cinnamic aldehyde results in increased expression of CXCL2 protein hexyl cinnamic aldehyde results in decreased expression of CXCL2 protein |
CTD |
PMID:23178550 PMID:28826779 |
|
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
increases expression increases secretion |
EXP |
hexyl cinnamic aldehyde results in increased expression of CXCL8 mRNA hexyl cinnamic aldehyde results in increased secretion of CXCL8 protein |
CTD |
PMID:27965148 PMID:31958493 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
DIO2 |
iodothyronine deiodinase 2 |
decreases activity |
EXP |
hexyl cinnamic aldehyde results in decreased activity of DIO2 protein |
CTD |
PMID:30561685 |
|
NCBI chr14:80,197,526...80,231,057
Ensembl chr14:80,197,526...80,387,757
|
|
G |
DIO3 |
iodothyronine deiodinase 3 |
decreases activity |
EXP |
hexyl cinnamic aldehyde results in decreased activity of DIO3 protein |
CTD |
PMID:30561685 |
|
NCBI chr14:101,561,495...101,563,452
Ensembl chr14:101,560,139...101,563,452
|
|
G |
E2F1 |
E2F transcription factor 1 |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of E2F1 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385
|
|
G |
FABP7 |
fatty acid binding protein 7 |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of FABP7 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 6:122,749,201...122,784,074
Ensembl chr 6:122,779,716...122,784,074
|
|
G |
FECH |
ferrochelatase |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of FECH mRNA |
CTD |
PMID:20566472 |
|
NCBI chr18:57,544,377...57,586,702
Ensembl chr18:57,544,377...57,586,732
|
|
G |
FTL |
ferritin light chain |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of FTL mRNA |
CTD |
PMID:20566472 |
|
NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,966,879
|
|
G |
FXYD4 |
FXYD domain containing ion transport regulator 4 |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of FXYD4 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr10:43,371,636...43,376,335
Ensembl chr10:43,371,636...43,376,335
|
|
G |
G6PD |
glucose-6-phosphate dehydrogenase |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of G6PD mRNA |
CTD |
PMID:20566472 |
|
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
|
|
G |
GCLC |
glutamate-cysteine ligase catalytic subunit |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of GCLC mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
|
|
G |
GCLM |
glutamate-cysteine ligase modifier subunit |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of GCLM mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
|
|
G |
GPX3 |
glutathione peroxidase 3 |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of GPX3 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 5:151,020,591...151,028,988
Ensembl chr 5:151,020,591...151,028,988
|
|
G |
GSR |
glutathione-disulfide reductase |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of GSR mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
GZMB |
granzyme B |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of GZMB mRNA |
CTD |
PMID:22302311 |
|
NCBI chr14:24,630,954...24,634,190
Ensembl chr14:24,630,954...24,634,267
|
|
G |
HMOX1 |
heme oxygenase 1 |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of HMOX1 mRNA |
CTD |
PMID:20566472 PMID:26244607 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
IFNG |
interferon gamma |
increases secretion |
ISO |
hexyl cinnamic aldehyde results in increased secretion of IFNG protein |
CTD |
PMID:22245253 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL12B |
interleukin 12B |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of IL12B mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
|
|
G |
IL17A |
interleukin 17A |
increases expression |
ISO |
hexyl cinnamic aldehyde results in increased expression of IL17A mRNA; hexyl cinnamic aldehyde results in increased expression of IL17A protein |
CTD |
PMID:28826779 |
|
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
IL1A |
interleukin 1 alpha |
increases expression |
ISO |
hexyl cinnamic aldehyde results in increased expression of IL1A protein |
CTD |
PMID:23178550 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL2 |
interleukin 2 |
increases secretion increases expression |
ISO |
hexyl cinnamic aldehyde results in increased secretion of IL2 protein hexyl cinnamic aldehyde results in increased expression of IL2 protein |
CTD |
PMID:22245253 PMID:22381623 |
|
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
|
|
G |
IL21 |
interleukin 21 |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of IL21 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 4:122,610,108...122,621,066
Ensembl chr 4:122,610,108...122,621,066
|
|
G |
IL2RA |
interleukin 2 receptor subunit alpha |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of IL2RA mRNA |
CTD |
PMID:22302311 |
|
NCBI chr10:6,010,689...6,062,367
Ensembl chr10:6,010,689...6,062,370
|
|
G |
IL4 |
interleukin 4 |
affects expression multiple interactions |
ISO EXP |
hexyl cinnamic aldehyde affects the expression of IL4 mRNA [hexyl cinnamic aldehyde co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD80 protein; [hexyl cinnamic aldehyde co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD86 protein |
CTD |
PMID:22302311 PMID:31958493 |
|
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IL4R |
interleukin 4 receptor |
increases expression |
ISO |
hexyl cinnamic aldehyde results in increased expression of IL4RA protein |
CTD |
PMID:22381623 |
|
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
|
|
G |
IL6 |
interleukin 6 |
increases secretion |
ISO |
hexyl cinnamic aldehyde results in increased secretion of IL6 protein |
CTD |
PMID:22245253 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
ITGAV |
integrin subunit alpha V |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of ITGAV mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 2:186,590,056...186,680,901
Ensembl chr 2:186,590,010...186,680,901
|
|
G |
MAFF |
MAF bZIP transcription factor F |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of MAFF mRNA |
CTD |
PMID:20566472 |
|
NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507
|
|
G |
MAFG |
MAF bZIP transcription factor G |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of MAFG mRNA |
CTD |
PMID:20566472 |
|
NCBI chr17:81,918,270...81,931,244
Ensembl chr17:81,918,270...81,927,735
|
|
G |
MAFK |
MAF bZIP transcription factor K |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of MAFK mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 7:1,530,702...1,543,043
Ensembl chr 7:1,530,702...1,543,043
|
|
G |
ME1 |
malic enzyme 1 |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of ME1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
|
|
G |
MGST1 |
microsomal glutathione S-transferase 1 |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of MGST1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr12:16,347,115...16,593,331
Ensembl chr12:16,347,142...16,609,259
|
|
G |
MIR146A |
microRNA 146a |
multiple interactions increases expression |
EXP |
PRKCB protein affects the reaction [hexyl cinnamic aldehyde results in increased expression of MIR146A mRNA] |
CTD |
PMID:37326882 |
|
NCBI chr 5:160,485,352...160,485,450
Ensembl chr 5:160,485,352...160,485,450
|
|
G |
MIR27A |
microRNA 27a |
decreases expression |
EXP |
hexyl cinnamic aldehyde results in decreased expression of MIR27A mRNA |
CTD |
PMID:37326882 |
|
NCBI chr19:13,836,440...13,836,517
Ensembl chr19:13,836,440...13,836,517
|
|
G |
MKI67 |
marker of proliferation Ki-67 |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of MKI67 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
|
|
G |
MMP10 |
matrix metallopeptidase 10 |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of MMP10 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr11:102,770,502...102,780,628
Ensembl chr11:102,770,502...102,780,628
|
|
G |
MT1X |
metallothionein 1X |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of MT1X mRNA |
CTD |
PMID:20566472 |
|
NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of NQO1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
NTS |
neurotensin |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of NTS mRNA |
CTD |
PMID:22302311 |
|
NCBI chr12:85,874,295...85,882,992
Ensembl chr12:85,874,295...85,882,992
|
|
G |
PGD |
phosphogluconate dehydrogenase |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of PGD mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 1:10,399,064...10,420,511
Ensembl chr 1:10,398,592...10,420,511
|
|
G |
PRKCB |
protein kinase C beta |
multiple interactions |
EXP |
PRKCB protein affects the reaction [hexyl cinnamic aldehyde results in increased expression of CD86 protein]; PRKCB protein affects the reaction [hexyl cinnamic aldehyde results in increased expression of MIR146A mRNA] |
CTD |
PMID:37326882 |
|
NCBI chr16:23,835,983...24,220,611
Ensembl chr16:23,835,983...24,220,611
|
|
G |
PTGR1 |
prostaglandin reductase 1 |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of PTGR1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 9:111,549,722...111,599,647
Ensembl chr 9:111,549,722...111,599,893
|
|
G |
SOD1 |
superoxide dismutase 1 |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of SOD1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SOD2 |
superoxide dismutase 2 |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of SOD2 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
|
|
G |
SOD3 |
superoxide dismutase 3 |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of SOD3 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 4:24,795,573...24,800,842
Ensembl chr 4:24,789,912...24,800,842
|
|
G |
SRXN1 |
sulfiredoxin 1 |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of SRXN1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr20:646,615...653,200
Ensembl chr20:646,615...653,200
|
|
G |
THBS1 |
thrombospondin 1 |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of THBS1 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466
|
|
G |
THBS4 |
thrombospondin 4 |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of THBS4 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 5:79,991,332...80,083,287
Ensembl chr 5:79,991,311...80,083,287
|
|
G |
TNF |
tumor necrosis factor |
increases expression multiple interactions |
ISO EXP |
hexyl cinnamic aldehyde results in increased expression of TNF mRNA [hexyl cinnamic aldehyde co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD80 protein; [hexyl cinnamic aldehyde co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD86 protein |
CTD |
PMID:28826779 PMID:31958493 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TRPM6 |
transient receptor potential cation channel subfamily M member 6 |
affects expression |
ISO |
hexyl cinnamic aldehyde affects the expression of TRPM6 mRNA |
CTD |
PMID:22302311 |
|
NCBI chr 9:74,722,495...74,887,921
Ensembl chr 9:74,722,495...74,888,094
|
|
G |
TXN2 |
thioredoxin 2 |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of TXN2 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr22:36,467,046...36,481,640
Ensembl chr22:36,467,046...36,481,640
|
|
G |
TXNRD1 |
thioredoxin reductase 1 |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of TXNRD1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
|
|
G |
TXNRD2 |
thioredoxin reductase 2 |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of TXNRD2 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr22:19,875,522...19,941,818
Ensembl chr22:19,875,517...19,941,820
|
|
G |
UGT1A6 |
UDP glucuronosyltransferase family 1 member A6 |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of UGT1A6 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 2:233,691,702...233,773,300
Ensembl chr 2:233,691,607...233,773,300
|
|
G |
VEGFA |
vascular endothelial growth factor A |
increases expression |
EXP |
hexyl cinnamic aldehyde results in increased expression of VEGFA protein |
CTD |
PMID:25617811 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
increases expression |
EXP |
coniferaldehyde results in increased expression of ABCC2 mRNA |
CTD |
PMID:26275128 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
ABCC3 |
ATP binding cassette subfamily C member 3 |
increases expression |
EXP |
coniferaldehyde results in increased expression of ABCC3 mRNA |
CTD |
PMID:26275128 |
|
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
|
|
G |
AKR1C1 |
aldo-keto reductase family 1 member C1 |
increases expression multiple interactions |
EXP |
coniferaldehyde results in increased expression of AKR1C1 mRNA; coniferaldehyde results in increased expression of AKR1C1 protein NFE2L2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of AKR1C1 protein] |
CTD |
PMID:26275128 |
|
NCBI chr10:4,963,415...4,983,283
Ensembl chr10:4,963,253...4,983,283
|
|
G |
AKR1C2 |
aldo-keto reductase family 1 member C2 |
increases expression |
EXP |
coniferaldehyde results in increased expression of AKR1C2 mRNA; coniferaldehyde results in increased expression of AKR1C2 protein |
CTD |
PMID:26275128 |
|
NCBI chr10:4,987,775...5,018,000
Ensembl chr10:4,987,775...5,018,031
|
|
G |
AKR1C3 |
aldo-keto reductase family 1 member C3 |
increases expression |
EXP |
coniferaldehyde results in increased expression of AKR1C3 mRNA |
CTD |
PMID:26275128 |
|
NCBI chr10:5,048,781...5,107,686
Ensembl chr10:5,035,354...5,107,686
|
|
G |
GCLC |
glutamate-cysteine ligase catalytic subunit |
increases expression |
EXP |
coniferaldehyde results in increased expression of GCLC mRNA |
CTD |
PMID:26275128 |
|
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
|
|
G |
GCLM |
glutamate-cysteine ligase modifier subunit |
increases expression |
EXP |
coniferaldehyde results in increased expression of GCLM mRNA |
CTD |
PMID:26275128 |
|
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
|
|
G |
GSR |
glutathione-disulfide reductase |
increases expression |
EXP ISO |
coniferaldehyde results in increased expression of GSR mRNA coniferaldehyde results in increased expression of GSR protein |
CTD |
PMID:26275128 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions increases expression |
EXP ISO |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; MAPK14 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; MAPKAPK2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; NFE2L2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; PKN3 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; Ro 31-8220 inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; SB 203580 inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein] coniferaldehyde results in increased expression of HMOX1 mRNA; coniferaldehyde results in increased expression of HMOX1 protein |
CTD |
PMID:26275128 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
IFNG |
interferon gamma |
multiple interactions |
EXP |
coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of NOS2 protein]; coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased phosphorylation of JAK2 protein]; coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased phosphorylation of STAT1 protein] |
CTD |
PMID:27378624 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
JAK2 |
Janus kinase 2 |
multiple interactions |
EXP ISO |
coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased phosphorylation of JAK2 protein] coniferaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of JAK2 protein] |
CTD |
PMID:27378624 |
|
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
|
|
G |
MAPK14 |
mitogen-activated protein kinase 14 |
multiple interactions |
EXP |
MAPK14 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein]; MAPK14 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein] |
CTD |
PMID:26275128 |
|
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
|
|
G |
MAPKAPK2 |
MAPK activated protein kinase 2 |
multiple interactions |
EXP |
MAPKAPK2 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein]; MAPKAPK2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein] |
CTD |
PMID:26275128 |
|
NCBI chr 1:206,684,905...206,734,281
Ensembl chr 1:206,684,905...206,734,281
|
|
G |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
increases expression multiple interactions |
EXP |
coniferaldehyde results in increased expression of MUC5AC mRNA 2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [coniferaldehyde results in increased expression of MUC5AC mRNA]; A 967079 inhibits the reaction [coniferaldehyde results in increased expression of MUC5AC mRNA]; coniferaldehyde results in increased expression of and results in increased secretion of MUC5AC protein; TWS 119 inhibits the reaction [coniferaldehyde results in increased expression of MUC5AC mRNA] |
CTD |
PMID:31944254 |
|
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions increases expression |
EXP ISO |
coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein; MAPK14 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein]; MAPKAPK2 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein]; NFE2L2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of AKR1C1 protein]; NFE2L2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; PKN3 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein] coniferaldehyde results in increased expression of NFE2L2 protein |
CTD |
PMID:26275128 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
EXP ISO |
coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of NOS2 protein] coniferaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 mRNA]; coniferaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 protein] |
CTD |
PMID:27378624 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
coniferaldehyde results in increased expression of NQO1 protein |
CTD |
PMID:26275128 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
PKN3 |
protein kinase N3 |
multiple interactions |
EXP |
PKN3 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein]; PKN3 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein] |
CTD |
PMID:26275128 |
|
NCBI chr 9:128,702,503...128,720,916
Ensembl chr 9:128,702,503...128,720,916
|
|
G |
STAT1 |
signal transducer and activator of transcription 1 |
multiple interactions |
EXP ISO |
coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased phosphorylation of STAT1 protein] coniferaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of STAT1 protein modified form]; coniferaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of STAT1 protein] |
CTD |
PMID:27378624 |
|
NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
EXP |
coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of NOS2 protein]; coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased phosphorylation of JAK2 protein]; coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased phosphorylation of STAT1 protein] |
CTD |
PMID:27378624 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TRPA1 |
transient receptor potential cation channel subfamily A member 1 |
increases activity |
EXP |
coniferaldehyde results in increased activity of TRPA1 protein |
CTD |
PMID:23541125 |
|
NCBI chr 8:72,021,250...72,090,010
Ensembl chr 8:72,019,917...72,075,584
|
|
G |
TXNRD1 |
thioredoxin reductase 1 |
increases expression |
EXP |
coniferaldehyde results in increased expression of TXNRD1 mRNA |
CTD |
PMID:26275128 |
|
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
|
|